Global Tuberculosis Diagnostic Market: Industry Analysis and Forecast (2020-2026) by Test Type, End-Users and Region

Global Tuberculosis Diagnostic Market is expected to grow at a CAGR of 4.82% during the forecast period. Global Tuberculosis Diagnostic Market is expected to reach US$ 4.22 Bn. by 2026.

Global Tuberculosis Diagnostic Market Overview:

Tuberculosis or TB is an infectious disease caused by Mycobacterium tuberculosis bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms and this is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected.

Global Tuberculosis Diagnostic Market Dynamics:

Rising Burden of Tuberculosis and Multi-drug Resistant Tuberculosis (MDR TB) are the primary factors driving the market growth. According to the World Health Organization (WHO), about 10 million people are affected by tuberculosis, each year. Further, tuberculosis is the leading cause of death from a single infectious agent, ranking above HIV/AIDS. The rise in initiatives by governments and independent organizations to control the spread of tuberculosis is also contributing to the growth of the global tuberculosis diagnostics market. An increase in expenditure on R&D activities for the development of novel tuberculosis diagnostic procedures will be a major factor for the growth of the tuberculosis diagnostics market growth in the forecast period. However, the high cost associated with the Tuberculosis testing procedure may hamper the market growth. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Tuberculosis Diagnostic Market Segment Analysis:

The Global Tuberculosis Diagnostic Market is segmented on the basis of Test Type and End-users. Based on Test Type, the Nucleic Acid Testing segment is projected to hold a significant market share. Nucleic acid testing of tuberculosis provides a higher level of accuracy and higher speed than culture-based tests, which is a factor driving the growth of the nucleic acid testing segment. The segment is expected to witness a CAGR of 5.4% over the forecast years. Global Tuberculosis Diagnostic Market1 To Know About The Research Methodology :- Request Free Sample Report

Global Tuberculosis Diagnostic Market Regional Insights:

Global Tuberculosis Diagnostic Market2 Asia Pacific is expected to witness lucrative market growth during forecast period. Due to the high burden of tuberculosis as well as the rapid proliferation of this disease the region is expected to dominate the market. Countries, such as India, China, Indonesia, and Afghanistan are among the top-priority countries for the control of communicable diseases, according to the WHO. China and India registered the highest number of new cases of tuberculosis annually, followed by African and Latin American countries. The report also helps in understanding Global Tuberculosis Diagnostic Market dynamics, structure by analyzing the market segments and project the Global Tuberculosis Diagnostic Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Tuberculosis Diagnostic Market make the report investor’s guide. Key Developments: In June 2018, Qiagen set up new guidelines from the American Academy of Pediatrics (AAP) for screening children as young as two years old, for latent tuberculosis infection.

Global Tuberculosis Diagnostic Market Scope: Inquire before buying

Global Tuberculosis Diagnostic Market3

Global Tuberculosis Diagnostic Market, By Region:

• North America • Europe • South America • MEA • APAC

Global Tuberculosis Diagnostic Market, key players:

• Thermo Fisher Scientific, Inc. • Alere, Inc. • Becton • Dickinson and Company • F. Hoffmann-La Roche AG • LIONEX Diagnostics & Therapeutics GmbH • Danaher Corporation • Creative Diagnostics • QIAGEN • Oxford Immunotec Ltd. • Hologic, Inc. • Cepheid • Akonni Biosystems, Inc. • bioMerieux SA • Epistem Ltd.

Global Tuberculosis Diagnostic Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Tuberculosis Diagnostic Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Tuberculosis Diagnostic Market 3.4. Geographical Snapshot of the Tuberculosis Diagnostic Market, By Manufacturer share 4. Global Tuberculosis Diagnostic Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Tuberculosis Diagnostic Market 5. Supply Side and Demand Side Indicators 6. Global Tuberculosis Diagnostic Market Analysis and Forecast, 2019-2026 6.1. Global Tuberculosis Diagnostic Market Size & Y-o-Y Growth Analysis. 7. Global Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 7.1.1. Radiographic Test 7.1.2. Nucleic Acid Testing 7.1.3. Cytokine Detection Test 7.1.4. Other 7.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 7.2.1. Hospital/Clinics 7.2.2. Diagnostics/Research Laboratory 7.2.3. Other 8. Global Tuberculosis Diagnostic Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 9.1.1. Radiographic Test 9.1.2. Nucleic Acid Testing 9.1.3. Cytokine Detection Test 9.1.4. Other 9.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 9.2.1. Hospital/Clinics 9.2.2. Diagnostics/Research Laboratory 9.2.3. Other 10. North America Tuberculosis Diagnostic Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 12. Canada Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 13. Mexico Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 14. Europe Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 15. Europe Tuberculosis Diagnostic Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 17. France Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 18. Germany Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 19. Italy Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 20. Spain Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 21. Sweden Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 22. CIS Countries Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 23. Rest of Europe Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 24. Asia Pacific Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 25. Asia Pacific Tuberculosis Diagnostic Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 27. India Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 28. Japan Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 29. South Korea Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 30. Australia Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 31. ASEAN Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 32. Rest of Asia Pacific Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 33. Middle East Africa Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 34. Middle East Africa Tuberculosis Diagnostic Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 36. GCC Countries Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 37. Egypt Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 38. Nigeria Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 39. Rest of ME&A Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 40. South America Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 41. South America Tuberculosis Diagnostic Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 43. Argentina Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 44. Rest of South America Tuberculosis Diagnostic Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Test Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By End users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Tuberculosis Diagnostic Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Thermo Fisher Scientific, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Alere, Inc. 45.3.3. Becton 45.3.4. Dickinson and Company 45.3.5. F. Hoffmann-La Roche AG 45.3.6. LIONEX Diagnostics & Therapeutics GmbH 45.3.7. Danaher Corporation 45.3.8. Creative Diagnostics 45.3.9. QIAGEN 45.3.10. Oxford Immunotec Ltd. 45.3.11. Hologic, Inc. 45.3.12. Cepheid 45.3.13. Akonni Biosystems, Inc. 45.3.14. bioMerieux SA 45.3.15. Epistem Ltd. 46. Primary Key Insights

About This Report

Report ID 94559
Category Healthcare
Published Date April 2021
Updated Date Nov 2021
Contact Us